A Safety and Efficacy Study Comparing Naltrexone SR/Bupropion SR and Placebo in Obese Subjects With Type 2 Diabetes
Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is determine whether the combination of naltrexone SR and bupropion
SR is safe and effective in treating obesity in subjects with type 2 diabetes.